1. Home
  2. >Providers
  3. >Pharmacogenomics
  4. >Comprehensive Pharmacogenomics Pgx Panel
Skip to main content

Comprehensive Pharmacogenomics (PGx) Panel

A comprehensive 27-gene pharmacogenomic panel for optimizing medication selection and dosing across cancer, cardiovascular disease, pain, mental health, and other conditions, powered by the Helix Exome+® platform.

Turnaround

6-9 days

Requery (SOQO)

≤ 5 minutes

Genes Tested

27

Panel Description

This test evaluates a patient’s metabolizer status for 27 genes, which can aid in appropriate medication selection and dosing to reduce risk of side effects and treatment failure for cancer, cardiovascular disease, pain, mental health and other conditions. Any information provided for drugs listed under "Limited Evidence Drug-Gene Associations" is provided for informational use only. For sections titled “Limited Evidence Drug-Gene Associations,” no interpretation of expected drug response is provided due to a lack of sufficient evidence and/or available guidelines.

Order This Test

Contact our clinical team to order this panel or learn more.

(855) 699-1933
clinicalsupport@helix.com

Genes Tested

27 genes included in this panel

ABCB1ABCG2ATICCOMTCYP2C clusterCYP2C19CYP2C9CYP2D6CYP3A4CYP3A5CYP4F2DPYDF2F5GRK4HLA-BIFNL3IFNL4MT-RNR1MTHFRNUDT15OPRM1SLC19A1SLCO1B1TPMTUGT1A1VKORC1

Ordering Information

Turnaround Time

Typically 6-9 days (standard), Typically ≤ 5 minutes (requery)

Preferred Specimen

BD Vacutainer Whole Blood K2 EDTA Collection Tube 4mL or Oragene Dx Saliva Collection Kit

Shipping Instructions

Specimens to arrive at Helix within 96 hours of collection at ambient temperature.

Clinical Description

This test evaluates a patient’s metabolizer status for 27 genes, which can aid in appropriate medication selection and dosing to reduce risk of side effects and treatment failure for cancer, cardiovascular disease, pain, mental health and other conditions. Any information provided for drugs listed under "Limited Evidence Drug-Gene Associations" is provided for informational use only. For sections titled “Limited Evidence Drug-Gene Associations,” no interpretation of expected drug response is provided due to a lack of sufficient evidence and/or available guidelines.

Ready to order this test?

Contact our clinical team to order the Comprehensive Pharmacogenomics (PGx) Panel for your patients.